Press Releases
PCMA Statement on Senate Finance Committee Vote
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) issued the following statement on today’s vote in the Senate Finance
PCMA Statement on CMS’ Proposal to Promote the Use of Biosimilars in Medicare Part D
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) supports the Centers for Medicare and Medicaid Services’ (CMS) proposal to
Senate Finance Committee Bill Will Cost Taxpayers and is a $10 Billion Giveaway to Big Pharma
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement today on legislation introduced by Senate Finance
National Bureau of Economic Research Working Paper: “Delinking” Proposals that Restrict PBM Incentives to Secure Rx Savings Will Increase Drug Prices and Provide $10B Giveaway for Big Pharma
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) today issued the following statement on a new research paper, “Ending
PCMA Statement on Legislation Introduced in the House of Representatives
(Washington, D.C.) — PCMA issued the following statement on legislation introduced in the House of Representatives: Legislation introduced in U.S.
PCMA Statement on the Tenth Circuit’s Decision in PCMA v. Mulready
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) applauds the recent ruling by the U.S. Court of Appeals for
PCMA Statement on House Ways and Means Committee and Senate Finance Committee Legislation
What Problem is Congress Trying to Solve? (Washington D.C.) – The Pharmaceutical Care Management Association released the following statement on
PCMA Statement on Federal Trade Commission Vote on PBM Advocacy
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) issued the following statement on today’s vote by the Federal Trade
